World's Best Scientists 2026 revealed!
Katerina Politi

Katerina Politi

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 53 2355 2120 1164 1036 325 22778

Katerina Politi publications per year

The chart shows the history of publications by Katerina Politi between 1984 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Katerina Politi published across 43 years, from 1984 to 2026, averaging 14.3 papers a year. Output peaked at 250 publications in 2023. 35 of the 617 publications appeared in the last two years.

No. of publications
50 100 150 200 250
Bar chart. Horizontal axis: year, 1984 to 2026. Vertical axis: number of publications, 0 to 250. Peak 250 publications in 2023. 1984: 1 publication 1985: 1 publication 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 1 publication 1997: 0 publications 1998: 0 publications 1999: 0 publications 2000: 0 publications 2001: 0 publications 2002: 3 publications 2003: 0 publications 2004: 5 publications 2005: 2 publications 2006: 6 publications 2007: 4 publications 2008: 3 publications 2009: 2 publications 2010: 3 publications 2011: 5 publications 2012: 10 publications 2013: 7 publications 2014: 10 publications 2015: 10 publications 2016: 9 publications 2017: 18 publications 2018: 12 publications 2019: 15 publications 2020: 15 publications 2021: 15 publications 2022: 19 publications 2023: 250 publications 2024: 156 publications 2025: 34 publications 2026: 1 publication
1984 2026

617 publications in total across all disciplines

View publications per year as a table
Katerina Politi: publications per year, 1984 to 2026
Year Publications
1984 1
1985 1
1986 0
1987 0
1988 0
1989 0
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 1
1997 0
1998 0
1999 0
2000 0
2001 0
2002 3
2003 0
2004 5
2005 2
2006 6
2007 4
2008 3
2009 2
2010 3
2011 5
2012 10
2013 7
2014 10
2015 10
2016 9
2017 18
2018 12
2019 15
2020 15
2021 15
2022 19
2023 250
2024 156
2025 34
2026 1
Total 617
Download as CSV

Katerina Politi publications per year - data summary

  • Katerina Politi, a Molecular Biology scholar from Yale University, has 617 publications recorded across 43 years, from 1984 to 2026.
  • The oldest publication on record dates to 1984 and the most recent to 2026.
  • The most productive year is 2023, with 250 publications.
  • The least productive years with any output are 1984, 1985, 1996 and 2026, with 1 publication each.
  • 16 of the 43 years in the span carry no publications at all (1986, 1987, 1988, 1989 and others).
  • The rate of publication averages 14.3 papers per year over the whole span, or 22.9 per year counting only the 27 years with at least one publication.
  • The last 5 years on the chart (2022-2026) hold 460 publications, 75% of the career total.
  • Split into equal eras - 1984-1998: 3 publications (0.2 per year); 1999-2013: 50 publications (3.3 per year); 2014-2026: 564 publications (43.4 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Katerina Politi publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Katerina Politi sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 317–326 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 325 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41 325
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Katerina Politi publication distribution in Molecular Biology in 2026 - data summary

  • The chart plots the publication count of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 53 ranges running from 47–56 to 564+ publications.
  • Katerina Politi, a Molecular Biology scholar from Yale University, records 325 publications - the 84th percentile of the discipline.
  • 84% of ranked Molecular Biology scientists score the same or lower than Katerina Politi, and about 16% score higher.
  • The median of the discipline falls in the 177–186 publications range, and Katerina Politi ranks above the median.
  • The most crowded range is 117–126 publications, holding 177 scientists (6% of the field).
  • 53% of the field sits in the lowest quarter of the value range (up to 177–186 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 564 publications or more, 100 scientists in all (3% of the field).

Katerina Politi D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Katerina Politi sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 52–53 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 53 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106 53
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Katerina Politi D-index placement in Molecular Biology in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 54 ranges running from 40–41 to 145+ D-Index.
  • Katerina Politi, a Molecular Biology scholar from Yale University, records 53 D-Index - the 24th percentile of the discipline.
  • 24% of ranked Molecular Biology scientists score the same or lower than Katerina Politi, and about 76% score higher.
  • The median of the discipline falls in the 68–69 D-Index range, and Katerina Politi ranks below the median.
  • The most crowded range is 64–65 D-Index, holding 131 scientists (4% of the field).
  • 50% of the field sits in the lowest quarter of the value range (up to 66–67 D-Index), so the distribution leans towards the lower end of the scale.
  • The final bar has no upper bound: it groups every scientist with 145 D-Index or more, 100 scientists in all (3% of the field).

Overview

Katerina Politi is affiliated with Yale University in the United States, with a research focus spanning biochemistry, genetics, molecular biology, and medicine. Their work encompasses a broad range of topics primarily related to lung cancer and cancer biology, including cancer genomics, diagnostics, and immunotherapy.

Their main fields of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these fields, notable subfields of research are:

  • Molecular Biology
  • Oncology
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Immunology

The primary topics of Politi's work involve:

  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • RNA modifications and cancer
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Immune cells in cancer

Katerina Politi's recent publication record features studies addressing host factors in viral infections, cancer cell biology, and immunotherapy approaches in lung cancer. Representative papers include:

  • Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection (2020, Cell)
  • Cycling cancer persister cells arise from lineages with distinct programs (2021, Nature)
  • Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer (2022, Nature Communications)
  • Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo (2021, Cancer Discovery)
  • Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC (2022, JCI Insight)

Frequent coauthors collaborating with Politi include:

  • Sarah B. Goldberg
  • Giorgia Foggetti
  • Fernando J. de Miguel
  • Scott Gettinger
  • Camila Robles-Oteíza

The scientist has consistently published in journals and venues such as:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Nature Communications

Best Publications

  • EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

    William Pao;Vincent Miller;Maureen Zakowski;Jennifer Doherty

  • Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

    William Pao;Vincent A. Miller;Katerina A Politi;Gregory J. Riely

  • HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.

    Ken Takezawa;Valentina Pirazzoli;Maria E. Arcila;Caroline A. Nebhan

  • Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

    Scott Gettinger;Jungmin Choi;Katherine Hastings;Anna Truini

  • Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors

    Katerina Politi;Maureen F. Zakowski;Pang-Dian Fan;Emily A. Schonfeld

  • Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.

    Deborah B. Doroshow;Miguel F. Sanmamed;Katherine Hastings;Katerina Politi

  • Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.

    Jin Wei;Mia Madel Alfajaro;Peter C. DeWeirdt;Ruth E. Hanna

  • Update on Epidermal Growth Factor Receptor Mutations in Non–Small Cell Lung Cancer

    Gregory J. Riely;Katerina A. Politi;Vincent A. Miller;William Pao

  • Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer

    Lucia Regales;Yixuan Gong;Ronglai Shen;Elisa de Stanchina

  • Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas

    Yixuan Gong;Romel Somwar;Katerina Politi;Marissa Balak

  • Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

    Jacqulyne P. Robichaux;Yasir Y. Elamin;Zhi Tan;Brett W. Carter

  • Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA

    Sarah B. Goldberg;Azeet Narayan;Adam J. Kole;Roy H. Decker

  • Cycling cancer persister cells arise from lineages with distinct programs.

    Yaara Oren;Yaara Oren;Michael Tsabar;Michael Tsabar;Michael S. Cuoco;Liat Amir-Zilberstein

  • Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

    Martin L. Sos;Stefanie Fischer;Roland Ullrich;Martin Peifer

  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

    K. Hastings;H.A. Yu;H.A. Yu;W. Wei;F. Sanchez-Vega

  • Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

    Ila J Datar;Ila J Datar;Miguel F Sanmamed;Miguel F Sanmamed;Jun Wang;Brian S Henick;Brian S Henick

  • Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice

    Apostolos Klinakis;Matthias Szabolcs;Katerina Politi;Hippokratis Kiaris

  • Notch in mammary gland development and breast cancer

    Katerina Politi;Nikki Feirt;Jan Kitajewski

  • Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor

    Shouhong Xuan;Tadahiro Kitamura;Jun Nakae;Katerina Politi

  • Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer

    Elza C de Bruin;Catherine F Cowell;Patricia H Warne;Ming Jiang

Frequent Co-Authors

Scott N. Gettinger
Scott N. Gettinger Yale University
William Pao
William Pao Roche (United States)
Harold E. Varmus
Harold E. Varmus Cornell University
Roy S. Herbst
Roy S. Herbst Yale University
Susan M. Kaech
Susan M. Kaech Salk Institute for Biological Studies
David L. Rimm
David L. Rimm Yale University
Robert J. Homer
Robert J. Homer Yale University
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Kurt A. Schalper
Kurt A. Schalper Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying molecular biology in the USA paves the way for a variety of online degrees and career options. Many students who begin in the life sciences later find themselves interested in related fields that also offer online flexibility and strong employment prospects.

If you come from a military background or need extra support balancing your academic and service commitments, consider exploring military friendly online colleges. These institutions provide resources and schedules tailored to veterans and active-duty personnel.

For those drawn to human services, social work master programs online offer accessible pathways to careers in advocacy and mental health support. Similarly, students interested in behavior and cognition can pursue accelerated masters psychology programs to fast-track their entry into clinical or research roles.

You can also develop expertise in mental health and counseling with a fully online format through an online masters degree in mental health counseling. These flexible programs make it possible to build a meaningful career helping others, no matter your location or current life circumstances.

Best Scientists Citing Katerina Politi

Trending Scientists

Recently Published Articles